Antifibrinolytics gynaecology and obstetrics.
D000293:Adolescent; D000328:Adult; D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests / Q000379:methods; D002648:Child; D004716:Endometritis / Q000150:complications; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D005342:Fibrinolysis; D006801:Humans; D006965:Hyperplasia; D008599:Menstruation Disturbances / Q000188:drug therapy; D008875:Middle Aged; D010770:Phosphotransferases / Q000097:blood; D010958:Plasminogen / Q000032:analysis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D051381:Rats; D013927:Thrombosis / Q000188:drug therapy; D014592:Uterine Hemorrhage / Q000188:drug therapy* / Q000473:pathology; D014594:Uterine Neoplasms / Q000150:complications
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D005340:Fibrinogen; D010958:Plasminogen; D010770:Phosphotransferases; D005341:Fibrinolysin